114.73
Irhythm Holdings Inc stock is traded at $114.73, with a volume of 284.88K.
It is down -1.16% in the last 24 hours and down -5.84% over the past month.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
See More
Previous Close:
$116.56
Open:
$116.33
24h Volume:
284.88K
Relative Volume:
0.50
Market Cap:
$3.77B
Revenue:
$787.85M
Net Income/Loss:
$-27.78M
P/E Ratio:
-132.24
EPS:
-0.8676
Net Cash Flow:
$18.75M
1W Performance:
+1.20%
1M Performance:
-5.84%
6M Performance:
-38.28%
1Y Performance:
-19.26%
Irhythm Holdings Inc Stock (IRTC) Company Profile
Name
Irhythm Holdings Inc
Sector
Industry
Phone
415-632-5700
Address
699 8TH STREET, San Francisco, CA
Compare IRTC vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
IRTC
Irhythm Holdings Inc
|
114.58 | 3.83B | 787.85M | -27.78M | 18.75M | -0.8676 |
|
ABT
Abbott Laboratories
|
86.88 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
313.32 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
77.81 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
57.89 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
87.61 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Irhythm Holdings Inc Stock (IRTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-23-25 | Initiated | Evercore ISI | In-line |
| Aug-20-25 | Initiated | BofA Securities | Buy |
| May-02-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-03-24 | Resumed | Wells Fargo | Equal Weight |
| Oct-04-24 | Initiated | Goldman | Neutral |
| Jun-20-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-11-23 | Upgrade | Citigroup | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Feb-07-23 | Initiated | Wells Fargo | Overweight |
| Nov-07-22 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-09-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-06-22 | Initiated | Wolfe Research | Underperform |
| Feb-24-22 | Upgrade | Needham | Hold → Buy |
| Jan-18-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-12-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-11-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Dec-21-21 | Resumed | Canaccord Genuity | Buy |
| Dec-17-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-15-21 | Upgrade | Citigroup | Neutral → Buy |
| Jun-02-21 | Downgrade | Citigroup | Buy → Neutral |
| Apr-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-12-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-26-21 | Downgrade | Colliers Securities | Buy → Neutral |
| Jan-29-21 | Reiterated | Needham | Hold |
| Nov-17-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-11-20 | Initiated | Needham | Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Aug-07-20 | Upgrade | Colliers Securities | Neutral → Buy |
| Aug-05-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jan-10-20 | Initiated | William Blair | Outperform |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Oct-22-19 | Initiated | Oppenheimer | Perform |
| Feb-20-19 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Sep-13-18 | Reiterated | Canaccord Genuity | Buy |
| Sep-06-18 | Initiated | Chardan Capital Markets | Buy |
| Aug-02-18 | Upgrade | Dougherty & Company | Sell → Neutral |
| Jul-16-18 | Downgrade | Dougherty & Company | Neutral → Sell |
| Dec-01-17 | Initiated | Dougherty & Company | Neutral |
View All
Irhythm Holdings Inc Stock (IRTC) Latest News
IRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring A 55% Upside Potential - DirectorsTalk Interviews
Here's why you should retain IRTC stock in your portfolio for now - MSN
What iRhythm Holdings (IRTC)'s Sustained Zio Growth and 2027 AI Launch Plan Means For Shareholders - Sahm
Digital health firm iRhythm lines up June investor conference talks - Stock Titan
IRTC Stock Price, Quote & Chart | IRHYTHM HOLDINGS INC (NASDAQ:IRTC) - ChartMill
IRTC Maintains Buy Rating -- Price Target Lowered to $180 by B o - GuruFocus
iRhythm Holdings, Inc. Stock 12‑Month Price Target Cut to $180.93, Implies 59% Upside - TradingView
Bessemer Group Inc. Decreases Position in iRhythm Technologies $IRTC - MarketBeat
[SCHEDULE 13G] iRhythm Holdings, Inc. Passive Investment Disclosure (>5%) - Stock Titan
IRTC Should I Buy - Intellectia AI
IRTC: Q1 growth, LCD expansion, and AI-driven innovation position the business for continued momentum - TradingView
IRTC Technical Analysis | Trend, Signals & Chart Patterns | IRHYTHM HOLDINGS INC (NASDAQ:IRTC) - ChartMill
Irhythm Holdings Insider Sold Shares Worth $626,430, According to a Recent SEC Filing - Moomoo
Insider Buying: Abhijit Talwalkar Acquires Shares of iRhythm Hol - GuruFocus
Director at iRhythm (NASDAQ: IRTC) sells 5,312 shares in 10b5-1 trades - Stock Titan
IRTC (NASDAQ) director files Form 144 to sell 5,312 shares via exercise - Stock Titan
The sustainable advantages iRhythm Holdings (IRTC) is developing (Institutional Selling) 2026-05-11Value Investing - newser.com
IRhythm Holdings, Inc. (IRTC) Stock Analysis: High Growth Potential With A 52.61% Upside - DirectorsTalk Interviews
Net current asset value per share of iRhythm Holdings, Inc. – LSE:0A7L - TradingView
Will Strong Q1 Results And New Zio Data Change iRhythm Holdings' (IRTC) Narrative - Sahm
IRTC SEC FilingsiRhythm Holdings, Inc 10-K, 10-Q, 8-K Forms - Stock Titan
iRhythm Holdings, Inc. (IRTC) reports Q1 loss, tops revenue estimates - MSN
Sands Capital (IRTC) files Schedule 13G/A amendment on iRhythm ownership - Stock Titan
iRhythm stock rises on Medicare coverage update (IRTC:NASDAQ) - Seeking Alpha
Wall Street analysts predict a 57.21% upside in iRhythm Hldgs (IRTC): Here's what you should know - MSN
iRhythm Holdings CTO Lawrence Lee sells $122,491 in stock By Investing.com - Investing.com Nigeria
iRhythm Holdings CTO Lawrence Lee sells $122,491 in stock - Investing.com India
iRhythm (NASDAQ: IRTC) CTO sells 1,014 shares to cover RSU tax obligations - Stock Titan
Wall Street Analysts Predict a 57.21% Upside in IRHYTHM HLDGS (IRTC): Here's What You Should Know - Yahoo Finance
Why iRhythm Holdings, Inc. (IRTC) is a top momentum stock for the long term - MSN
iRhythm Holdings, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:IRTC) 2026-05-04 - Seeking Alpha
IRTC Stock Up on Q1 Earnings & Revenue Beat, FY26 Outlook Raised - Zacks Investment Research
Citi Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Raises Target Price to $157 - Moomoo
IRhythm Holdings, Inc. (IRTC) Stock Analysis: Is A 52.44% Upside Just Around The Corner? - DirectorsTalk Interviews
iRhythm Technologies (NASDAQ:IRTC) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
US$184: That's What Analysts Think iRhythm Holdings, Inc. (NASDAQ:IRTC) Is Worth After Its Latest Results - Yahoo Finance
iRhythm Technologies (NASDAQ:IRTC) Rating Increased to Buy at Wall Street Zen - MarketBeat
Irhythm Holdings Inc Stock (IRTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Irhythm Holdings Inc Stock (IRTC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| TALWALKAR ABHIJIT Y | Director |
May 11 '26 |
Sale |
117.93 |
5,312 |
626,430 |
20,299 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):